Stock info Enanta Pharmaceuticals Inc | Filter  Basic-Info

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc primarily operates in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent over the period 2006-2016. Over the past 5 years the sector is 147 percent higher.

The past year was a profitable year Enanta Pharmaceuticals Inc investors

Over the past year the company' stock lost around 2 percent. Over the past 5 years Enanta Pharmaceuticals Inc' stock lost at around 0 percent in value. Enanta Pharmaceuticals Inc's revenues between 2011 and 2015 were quite unstable and moved between 41,71 million dollars and 160,88 million dollars. Enanta Pharmaceuticals Inc's net incomes between 2011 and 2015 were very volatile and moved between 23,31 million dollars and 78,99 million dollars.

The American company didn't pay out any dividends (in the past 5 years).

Enanta Pharmaceuticals Inc financed with relatively a lot of debt

At the end of 2015 the American company had a balance sheet of around 246,01 million dollars. 9,85 million dollars (4 percent of the total balance sheet) was financed by debt. Last year the pharmaceutical company's price/earnings-ratio (PE) was around 12. So the investors valued the stock at 12 times 2015' earnings per share. We could say that based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 608,94 million dollars. At the end of 2015 the American company had around 18,67 million stocks listed.

At this page you find all Enanta Pharmaceuticals Inc's financial reports. More information about Enanta Pharmaceuticals Inc can be found it's website. .